FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297151133> ?p ?o ?g. }

• W4297151133 endingPage "2391" @default.
• W4297151133 startingPage "2391" @default.
• W4297151133 abstract "During phagocytosis, tumor-associated macrophages (TAMs) can incorporate genetic material from tumor cells. The incorporation of extra genetic material may be responsible for advanced malignant behavior observed in some TAMs, making TAMs potentially important players in cancer progression. More recently, similar cells were described in the blood as cancer-associated macrophage-like cells (CAMLs). CAMLs may be equivalent to TAMs cells in the blood, and they express macrophage markers. However, their origin is still unclear. In a previous study, we showed for the first time the distinct telomere 3D structure of circulating tumor cells (CTCs) in melanoma and other cancers. In the present pilot study, we investigated, comparatively, the 3D telomere structure of CAMLs, CTCs and leucocytes from nine melanoma patients with metastatic cutaneous melanoma stage IV. CTC capture was performed by size-based filtration followed by cytological and immunocytological evaluation. Three-dimensional Quantitative Fluorescent in situ Hybridization was performed to measure differences in five 3D telomere parameters. Telomere parameters, such as number, length, telomere aggregates, nuclear volume, and a/c ratio, were compared among different cellular types (CTCs, CAMLs, and normal leucocytes). Three telomere parameters were significantly different between CAMLs and leucocytes. The combination of two telomere parameters (telomere length against the number of telomeres) resulted in the identification of two CAMLs subpopulations with different levels of genomic instability. Those populations were classified as profile 1 and 2. Profile 2, characterized by a high number of short telomeres, was observed in four of the nine melanoma patients. To our knowledge, this is the first pilot study to investigate 3D telomere parameters as hallmarks of nuclear architecture in CAMLs' population in comparison to leucocytes from the same patient. Further studies involving a larger patient sample size are necessary to validate these findings and explore their potential prognostic value." @default.
• W4297151133 created "2022-09-27" @default.
• W4297151133 creator A5014425899 @default.
• W4297151133 creator A5025478490 @default.
• W4297151133 creator A5035559909 @default.
• W4297151133 creator A5062378722 @default.
• W4297151133 creator A5063900957 @default.
• W4297151133 creator A5082314520 @default.
• W4297151133 date "2022-09-25" @default.
• W4297151133 modified "2023-10-17" @default.
• W4297151133 title "Telomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients" @default.
• W4297151133 cites W110933786 @default.
• W4297151133 cites W1547146973 @default.
• W4297151133 cites W1877171832 @default.
• W4297151133 cites W1896639978 @default.
• W4297151133 cites W1990400836 @default.
• W4297151133 cites W2002219581 @default.
• W4297151133 cites W2018236302 @default.
• W4297151133 cites W2040151956 @default.
• W4297151133 cites W2058837304 @default.
• W4297151133 cites W2074974517 @default.
• W4297151133 cites W2085009992 @default.
• W4297151133 cites W2101195992 @default.
• W4297151133 cites W2105660237 @default.
• W4297151133 cites W2106027870 @default.
• W4297151133 cites W2116978375 @default.
• W4297151133 cites W2128035403 @default.
• W4297151133 cites W2133486096 @default.
• W4297151133 cites W2136806837 @default.
• W4297151133 cites W2158795833 @default.
• W4297151133 cites W2159999569 @default.
• W4297151133 cites W2160834915 @default.
• W4297151133 cites W2164918836 @default.
• W4297151133 cites W2205830781 @default.
• W4297151133 cites W2352719856 @default.
• W4297151133 cites W2365348826 @default.
• W4297151133 cites W2395483593 @default.
• W4297151133 cites W2560367415 @default.
• W4297151133 cites W2572174216 @default.
• W4297151133 cites W2605233023 @default.
• W4297151133 cites W2615301036 @default.
• W4297151133 cites W2728148734 @default.
• W4297151133 cites W2737655512 @default.
• W4297151133 cites W2747948215 @default.
• W4297151133 cites W2792183232 @default.
• W4297151133 cites W2792569303 @default.
• W4297151133 cites W2883420524 @default.
• W4297151133 cites W2929065785 @default.
• W4297151133 cites W2950755606 @default.
• W4297151133 cites W2960078024 @default.
• W4297151133 cites W2966919884 @default.
• W4297151133 cites W2980829587 @default.
• W4297151133 cites W3005906644 @default.
• W4297151133 cites W4243150695 @default.
• W4297151133 doi "https://doi.org/10.3390/biomedicines10102391" @default.
• W4297151133 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36289653" @default.
• W4297151133 hasPublicationYear "2022" @default.
• W4297151133 type Work @default.
• W4297151133 citedByCount "0" @default.
• W4297151133 crossrefType "journal-article" @default.
• W4297151133 hasAuthorship W4297151133A5014425899 @default.
• W4297151133 hasAuthorship W4297151133A5025478490 @default.
• W4297151133 hasAuthorship W4297151133A5035559909 @default.
• W4297151133 hasAuthorship W4297151133A5062378722 @default.
• W4297151133 hasAuthorship W4297151133A5063900957 @default.
• W4297151133 hasAuthorship W4297151133A5082314520 @default.
• W4297151133 hasBestOaLocation W42971511331 @default.
• W4297151133 hasConcept C121608353 @default.
• W4297151133 hasConcept C142724271 @default.
• W4297151133 hasConcept C177336024 @default.
• W4297151133 hasConcept C202751555 @default.
• W4297151133 hasConcept C203014093 @default.
• W4297151133 hasConcept C2777658100 @default.
• W4297151133 hasConcept C2779244956 @default.
• W4297151133 hasConcept C502942594 @default.
• W4297151133 hasConcept C54355233 @default.
• W4297151133 hasConcept C552990157 @default.
• W4297151133 hasConcept C71924100 @default.
• W4297151133 hasConcept C86803240 @default.
• W4297151133 hasConcept C96232424 @default.
• W4297151133 hasConceptScore W4297151133C121608353 @default.
• W4297151133 hasConceptScore W4297151133C142724271 @default.
• W4297151133 hasConceptScore W4297151133C177336024 @default.
• W4297151133 hasConceptScore W4297151133C202751555 @default.
• W4297151133 hasConceptScore W4297151133C203014093 @default.
• W4297151133 hasConceptScore W4297151133C2777658100 @default.
• W4297151133 hasConceptScore W4297151133C2779244956 @default.
• W4297151133 hasConceptScore W4297151133C502942594 @default.
• W4297151133 hasConceptScore W4297151133C54355233 @default.
• W4297151133 hasConceptScore W4297151133C552990157 @default.
• W4297151133 hasConceptScore W4297151133C71924100 @default.
• W4297151133 hasConceptScore W4297151133C86803240 @default.
• W4297151133 hasConceptScore W4297151133C96232424 @default.
• W4297151133 hasIssue "10" @default.
• W4297151133 hasLocation W42971511331 @default.
• W4297151133 hasLocation W42971511332 @default.
• W4297151133 hasLocation W42971511333 @default.
• W4297151133 hasLocation W42971511334 @default.

• next